In the realm of pharmaceutical manufacturing, the adoption of automated electronic systems such as Manufacturing Execution Systems (MES) and Electronic Batch Records (EBRs) is pivotal for enhancing operational efficiency. To streamline communication between various process systems and optimize manufacturing processes, the International Society of Automation’s (ISA) procedural model for batch automation, known as ISA-88, serves as a foundational framework of standards. This model acts as a universal language that facilitates seamless collaboration between individuals and systems in implementing automated batch systems. Recently, Pharmaceutical Technology engaged in a discussion with Jonathan Lustri, a life sciences industry consultant at Emerson Process Management, shedding light on the latest advancements in utilizing ISA-88 to synchronize MES with Distributed Control System (DCS) platforms.
Understanding the ISA-88 Design
In essence, ISA-88 outlines a standard for deploying batch process automation, encompassing both a procedural model and an equipment model. The procedural model delineates the hierarchy of objects utilized to configure batch processing logic, including master recipes, procedures, unit procedures, operations, and phases. These elements are structured into reusable software components, allowing for the swift implementation of common actions such as heating a tank without necessitating revalidation each time.
Addressing Challenges in MES and DCS Integration
An inherent challenge in integrating MES and DCS lies in managing the ISA-88 procedural model across distinct software systems. Both MES and DCS systems leverage this model, necessitating meticulous coordination during design, implementation, and operation to ensure synchronization during batch execution. Determining the system in which manufacturing activities should be executed poses another hurdle, with MES typically handling electronic batch record implementation in the pharmaceutical sector. Transitioning from paper batch records to an ISA-88 procedural model within the MES demands thorough analysis and integration with the ISA-88 batch model operational in the DCS.
Resolving Integration Issues
Opinions vary on the optimal approach to MES and DCS implementation, with a prevailing trend towards housing the master recipe within the DCS. This strategy capitalizes on automating processes using instrumentation and valves within the DCS while relegating manual activities to the MES. By designing the master procedural model within the DCS and leveraging it as the orchestrator, manual transactions are initiated by the DCS as needed. This streamlined approach minimizes the coordination required between MES workflows and DCS batch operations, simplifying system integration and change management.
Anticipated Advances in MES and DCS
Looking ahead, advancements in manufacturing are poised to enhance the technical transfer process from development to production. Companies are increasingly investing in standardizing data models across process development and manufacturing departments to expedite technical transfer and mitigate errors. By implementing standardized data models and product lifecycle management systems, organizations can streamline the transition from process development to manufacturing, fostering operational efficiency and reducing complexities.
In conclusion, the convergence of MES and process control through ISA-88 standards presents a transformative opportunity for pharmaceutical manufacturers to bolster efficiency and compliance in their operations. By embracing standardized frameworks and optimizing system integration, companies can navigate the evolving landscape of pharmaceutical manufacturing with agility and precision.
Key Takeaways:
– ISA-88 serves as a foundational framework for batch automation, facilitating seamless communication between MES and DCS systems.
– Coordinating MES and DCS integration involves challenges in managing the ISA-88 procedural model across different software platforms.
– Aligning the master recipe within the DCS and automating processes through instrumentation can streamline MES and DCS integration.
– Future advancements in MES and DCS focus on standardizing data models to expedite technical transfer and enhance operational efficiency.
Tags: process development, automation, formulation
Read more on pharmtech.com